BioGend Therapeutics Co., Ltd.
6733
Rank in Stocks
#20409
This company specializes in the development of innovative regenerative... This company specializes in the development of innovative regenerative bio-orthopedic products. Its current pipeline includes BiG-001 and BiG-006, both of which are osteoinductive bone graft substitutes. Additionally, it is advancing BiG-009, an autologous cartilage repair system. Established in 2016, the firm's operations are based in Taipei, Taiwan.
Share Price
$0.63255252
Last synced: 2026-11-10
Market Cap
$84.96M
Change (1 day)
-1.19%
Change (1 year)
-50.37%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BioGend Therapeutics Co., Ltd. (6733)
Category
Healthcare
EPS for BioGend Therapeutics Co., Ltd. (6733)
EPS as of June 2026 TTM: $-0.02
According to BioGend Therapeutics Co., Ltd.'s latest financial reports, its current EPS (TTM) is $-0.02. At the end of 2025 the company had an EPS of $-0.02, an increase over its 2024 EPS of $-0.03.
EPS history for BioGend Therapeutics Co., Ltd. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.02 | -16.50% |
| 2025 | $-0.02 | -23.88% |
| 2024 | $-0.03 | -31.84% |
| 2023 | $-0.04 | -27.40% |
| 2022 | $-0.06 | 18.22% |
| 2021 | $-0.05 | -15.41% |
| 2020 | $-0.06 | -13.10% |
| 2019 | $-0.07 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -93,872.46% |
US
|
|
| $-7.07 | 42,235.33% |
US
|
|
| $-5.29 | 31,576.65% |
AU
|
|
| $12.88 | -77,226.35% |
BE
|
|
| $21.56 | -129,201.80% |
NL
|
Questions about BioGend Therapeutics Co., Ltd.'s earnings per share (EPS)
What is BioGend Therapeutics Co., Ltd.'s earnings per share (EPS)?
BioGend Therapeutics Co., Ltd.'s earnings per share (EPS) over the last twelve months is $-0.02, as of Jun 2026.
What was BioGend Therapeutics Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, BioGend Therapeutics Co., Ltd.'s earnings per share (EPS) was $-0.02, compared with $-0.03 in 2024.
How has BioGend Therapeutics Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, BioGend Therapeutics Co., Ltd.'s earnings per share (EPS) was highest in 2025 ($-0.02) and lowest in 2022 ($-0.06).
How does BioGend Therapeutics Co., Ltd.'s earnings per share (EPS) compare with similar companies?
BioGend Therapeutics Co., Ltd.'s earnings per share (EPS) ($-0.02) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.